Trulieve Cannabis (OTC: TCNNF) reported its third-quarter results, resulting in a more than 2% increase in stock price, surpassing the S&P 500‘s 0.4% gain. The company achieved $288 million in revenue, reflecting a slight 1% rise from the same period in 2024. Its net loss, not adhering to GAAP, remained stable at $12 million ($0.07 per share). Investors reacted positively to the performance, fostering cautious optimism.
